Featured Companies

ANGLE – 55.5p

The announcement that AIM listed ANGLE (55.5p) has submitted an application to the US FDA for its Parsortix® system seeking clearance for use with metastatic breast cancer patients is likely to generate significant interest in the shares.  The submission to the FDA is the culmination of five years’ work which has included extensive...

Latest Newsletters

AIM MARKET

DX Group 17.25p

29 September 2020 - director share purchases Following the announcement of its annual results a couple of week's ago, a number of directors have bought...

ANGLE – 55.5p

The announcement that AIM listed ANGLE (55.5p) has submitted an application to the US FDA for its Parsortix® system seeking clearance for use with metastatic breast cancer...

MAIN MARKET

Investec – 138p

18 September 2020 - trading update The financial services and banking group Investec has issued a trading update for the five month period to 31...

Penny Stocks